Human herpesvirus 6A infection in CD46 transgenic mice: Viral persistence in the brain and increased production of proinflammatory chemokines via toll-like receptor 9

Journal of Virology

Volumn 88, Issue 10, 2014, Pages 5421-5436

  Reynaud, Joséphine M ^a,b,c,d   Jégou, Jean François ^a,b,c,d,e   Welsch, Jérémy C ^a,b,c,d   Horvat, Branka ^a,b,c,d  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b CNRS   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MEMBRANE COFACTOR PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 9; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; GLIAL CELL CULTURE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNOHISTOLOGY; INFECTION SENSITIVITY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; VIRUS INACTIVATION; VIRUS TRANSCRIPTION;

ANIMALS; ANTIGENS, CD46; BRAIN; CELLS, CULTURED; CHEMOKINES; DISEASE MODELS, ANIMAL; DNA, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NEUROGLIA; RECEPTORS, VIRUS; ROSEOLOVIRUS INFECTIONS; TOLL-LIKE RECEPTOR 9;

EID: 84899063724     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03763-13     Document Type: Article

References (85)

1. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, Diluca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Höllsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. 6 November 2013. Classification of HHV-6A and HHV-6B as distinct viruses. Arch. Virol. http://dx.doi.org/10.1007/s00705-013-1902-5.
2. Braun DK, Dominguez G, Pellett PE. 1997. Human herpesvirus 6. Clin. Microbiol. Rev. 10:521-567.
3. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
4. Luppi M, Barozzi P, Maiorana A, Marasca R, Torelli G. 1994. Human herpesvirus 6 infection in normal human brain tissue. J. Infect. Dis. 169: 943-944. http://dx.doi.org/10.1093/infdis/169.4.943.
5. Chan PK, Ng HK, Hui M, Ip M, Cheung JL, Cheng AF. 1999. Presence of human herpesviruses 6, 7, and 8DNAsequences in normal brain tissue. J. Med. Virol. 59:491-495. http://dx.doi.org/10.1002/(SICI)1096-9071(199912)59:4<491::AID-JMV113.0.CO;2-1
6. Chan PK, Ng HK, Hui M, Cheng AF. 2001. Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J. Med. Virol. 64:42-46. http://dx.doi.org/10.1002/jmv.1015.
7. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, Calogero A, Frati L, Faggioni A, Ragona G. 2001. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J. Med. Virol. 63:45-51. http://dx.doi.org/10.1002/1096-9071(200101)63:1<45::AID-JMV1006 3.0.CO;2-K.
8. Opsahl ML, Kennedy PGE. 2005. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128:516-527. http://dx.doi.org/10.1093/brain/awh390.
9. Zerr DM. 2006. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J. Clin. Virol. 37(Suppl 1):S52-S56. http://dx.doi.org/10.1016/S1386-6532(06)70012-9.
10. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. 1997. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3:1394-1397. http://dx.doi.org/10.1038/nm1297-1394.
11. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M. 2003. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol. 69:111-117. http://dx.doi.org/10.1002/jmv.10258.
12. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M. 1995. Plaqueassociated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92:7440-7444. http://dx.doi.org/10.1073/pnas.92.16.7440.
13. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM. 2003. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis. 187:1365-1376. http://dx.doi.org/10.1086/368172.
14. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817- 827. http://dx.doi.org/10.1016/S0092-8674(00)81678-5.
15. Källström H, Liszewski MK, Atkinson JP, Jonsson AB. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647. http://dx.doi.org/10.1046/j.1365-2958.1997.4841857.x.
16. Dörig RE, Marcil A, Chopra A, Richardson CD. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295- 305. http://dx.doi.org/10.1016/0092-8674(93)80071-L.
17. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin- Combe C, Gerlier D. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
18. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B. 2002. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 3:659-666.
19. Johnstone RW, Loveland BE. 1993. Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 79: 341-347.
20. Gardell JL, Dazin P, Islar J, Menge T, Genain CP, Lalive PH. 2006. Apoptotic effects of human herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity. J. Clin. Virol. 37(Suppl 1):S11-S16. http://dx.doi.org/10.1016/S1386-6532(06)70005-1.
21. Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hahn A, Jacobson S. 2005. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J. Neurovirol. 11:384-394. http://dx.doi.org/10.1080/13550280591002379.
22. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, González-Scarano F. 1998. The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J. Neurovirol. 4:486- 494. http://dx.doi.org/10.3109/13550289809113493.
23. Dietrich J, Blumberg BM, Roshal M, Baker JV, Hurley SD, Mayer-Pröschel M, Mock DJ. 2004. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J. Neurosci. 24:4875- 4883. http://dx.doi.org/10.1523/JNEUROSCI.5584-03.2004.
24. Donati D, Martinelli E, Cassiani-Ingoni R, Ahlqvist J, Hou J, Major EO, Jacobson S. 2005. Variant-specific tropism of human herpesvirus 6 in human astrocytes. J. Virol. 79:9439-9448. http://dx.doi.org/10.1128/JVI.79.15.9439-9448.2005.
25. De Filippis L, Foglieni C, Silva S, Vescovi AL, Lusso P, Malnati MS. 2006. Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. J. Clin. Virol. 37(Suppl 1):S27-S32. http://dx.doi.org/10.1016/S1386-6532(06)70008-7.
26. Gu B, Zhang G-F, Li L-Y, Zhou F, Feng D-J, Ding C-L, Chi J, Zhang C, Guo D-D, Wang J-F, Zhou H, Yao K, Hu W-X. 2011. Human herpesvirus 6A induces apoptosis of primary human fetal astrocytes via both caspase-dependent and-independent pathways. Virol. J. 8:530. http://dx.doi.org/10.1186/1743-422X-8-530.
27. He J, McCarthy M, Zhou Y, Chandran B, Wood C. 1996. Infection of primary human fetal astrocytes by human herpesvirus 6. J. Virol. 70: 1296-1300.
28. Tang H, Serada S, Kawabata A, Ota M, Hayashi E, Naka T, Yamanishi K, Mori Y. 2013. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc. Natl. Acad. Sci. U. S. A. 110:9096-9099. http://dx.doi.org/10.1073/pnas.1305187110.
29. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. 1995. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 85: 1263-1271.
30. Li L, Gu B, Zhou F, Chi J, Wang F, Peng G, Xie F, Qing J, Feng D, Lu S, Yao K. 2011. Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase. J. Virol. 85:6774-6783. http://dx.doi.org/10.1128/JVI.02577-10.
31. Øster B, Bundgaard B, Höllsberg P. 2005. Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. J. Virol. 79:1961-1965. http://dx.doi.org/10.1128/JVI.79.3.1961-1965.2005.
32. Jaworska J, Gravel A, Fink K, Grandvaux N, Flamand L. 2007. Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J. Virol. 81:5737-5748. http://dx.doi.org/10.1128/JVI.02443-06.
33. Kofod-Olsen E, Ross-Hansen K, Schleimann MH, Jensen DK, Møller JML, Bundgaard B, Mikkelsen JG, Höllsberg P. 2012. U20 is responsible for human herpesvirus 6B inhibition of tumor necrosis factor receptordependent signaling and apoptosis. J. Virol. 86:11483-11492. http://dx.doi.org/10.1128/JVI.00847-12.
34. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, Gompels UA. 2000. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J. Immunol. 164:2396-2404. http://www.jimmunol.org/content/164/5/2396.
35. Mayne M, Cheadle C, Soldan SS, Cermelli C, Yamano Y, Akhyani N, Nagel JE, Taub DD, Becker KG, Jacobson S. 2001. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J. Virol. 75:11641- 11650. http://dx.doi.org/10.1128/JVI.75.23.11641-11650.2001.
36. Kikuta H, Nakane A, Lu H, Taguchi Y, Minagawa T, Matsumoto S. 1990. Interferon induction by human herpesvirus 6 in human mononuclear cells. J. Infect. Dis. 162:35-38. http://dx.doi.org/10.1093/infdis/162.1.35.
37. Flamand L, Stefanescu I, Menezes J. 1996. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Investig. 97:1373- 1381. http://dx.doi.org/10.1172/JCI118557.
38. Arena A, Liberto MC, Capozza AB, Focà A. 1997. Productive HHV-6 infection in differentiated U937 cells: role of TNF alpha in regulation of HHV-6. New Microbiol. 20:13-20.
39. Inagi R, Guntapong R, Nakao M, Ishino Y, Kawanishi K, Isegawa Y, Yamanishi K. 1996. Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2. J. Med. Virol. 49:34- 40. http://dx.doi.org/10.1002/(SICI)1096-9071(199605)49:1<34::AID-J MV63.0.CO;2-L.
40. Meeuwsen S, Persoon-Deen C, Bsibsi M, Bajramovic JJ, Ravid R, De Bolle L, van Noort JM. 2005. Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A. J. Neuroimmunol. 164:37-47. http://dx.doi.org/10.1016/j.jneuroim.2005.03.013.
41. Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, Garrafa E, Cassai E, Di Luca D. 2002. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J. Med. Virol. 67:528-533. http://dx.doi.org/10.1002/jmv.10133.
42. Grivel J-C, Santoro F, Chen S, Fagá G, Malnati MS, Ito Y, Margolis L, Lusso P. 2003. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J. Virol. 77:8280-8289. http://dx.doi.org/10.1128/JVI.77.15.8280-8289.2003.
43. Arbuckle JH, Medveczky PG. 2011. The molecular biology of human herpesvirus-6 latency and telomere integration. Microbes Infect. 13:731- 741. http://dx.doi.org/10.1016/j.micinf.2011.03.006.
44. Yalcin S, Mukai T, Kondo K, Ami Y, Okawa T, Kojima A, Kurata T, Yamanishi K. 1992. Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. J. Gen. Virol. 73(Part 7):1673- 1677. http://dx.doi.org/10.1099/0022-1317-73-7-1673.
45. Lusso P, Crowley RW, Malnati MS, Di Serio C, Ponzoni M, Biancotto A, Markham PD, Gallo RC. 2007. Human herpesvirus 6A accelerates AIDS progression in macaques. Proc. Natl. Acad. Sci. U. S. A. 104:5067- 5072. http://dx.doi.org/10.1073/pnas.0700929104.
46. Leibovitch E, Wohler JE, Cummings Macri SM, Motanic K, Harberts E, Gaitán MI, Maggi P, Ellis M, Westmoreland S, Silva A, Reich DS, Jacobson S. 2013. Novel marmoset (Callithrix jacchus) model of human herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization. PLoS Pathog. 9:e1003138. http://dx.doi.org/10.1371/journal.ppat.1003138.
47. Lusso P. 1996. Human herpesvirus 6 (HHV-6). Antiviral Res. 31:1-21. http://dx.doi.org/10.1016/0166-3542(96)00949-7.
48. Tsujimura A, Shida K, Kitamura M, Nomura M, Takeda J, Tanaka H, Matsumoto M, Matsumiya K, Okuyama A, Nishimune Y, Okabe M, Seya T. 1998. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330(Part 1):163-168.
49. Gobbi A, Stoddart CA, Malnati MS, Locatelli G, Santoro F, Abbey NW, Bare C, Linquist-Stepps V, Moreno MB, Herndier BG, Lusso P, Mc-Cune JM. 1999. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J. Exp. Med. 189:1953-1960. http://dx.doi.org/10.1084/jem.189.12.1953.
50. -/- mice. J. Virol. 87:12020-12028. http://dx.doi.org/10.1128/JVI.01556-13.
51. Shingai M, Inoue N, Okuno T, Okabe M, Akazawa T, Miyamoto Y, Ayata M, Honda K, Kurita-Taniguchi M, Matsumoto M, Ogura H, Taniguchi T, Seya T. 2005. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J. Immunol. 175:3252-3261. http://www.jimmunol.org/content/175/5/3252.
52. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921. http://dx.doi.org/10.1126/science.800 9221.
53. Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A, Raoul H, Horvat B. 2013. Type I interferon signaling protects mice from lethal henipavirus infection. J. Infect. Dis. 207:142-151. http://dx.doi.org/10.1093/infdis/jis653.
54. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45.
55. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55:611-622. http://dx.doi.org/10.1373/clinchem.2008.112797.
56. Katze MG, He Y, Gale M, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687. http://dx.doi.org/10.1038/nri888.
57. Johnstone RW, Russell SM, Loveland BE, McKenzie IF. 1993. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol. Immunol. 30:1231-1241. http://dx.doi.org/10.1016/0161-5890(93)90038-D.
58. Lopez C. 1975. Genetics of natural resistance to herpesvirus infections in mice. Nature 258:152-153. http://dx.doi.org/10.1038/258152a0.
59. Murakami Y, Tanimoto K, Fujiwara H, An J, Suemori K, Ochi T, Hasegawa H, Yasukawa M. 2010. Human herpesvirus 6 infection impairs Toll-like receptor signaling. Virol. J. 7:91. http://dx.doi.org/10.1186/1743-422X-7-91.
60. Nordström I, Eriksson K. 2012. HHV-6B induces IFN-Lambda1 responses in cord plasmacytoid dendritic cells through TLR9. PLoS One 7:e38683. http://dx.doi.org/10.1371/journal.pone.0038683.
61. Chi J, Wang F, Li L, Feng D, Qin J, Xie F, Zhou F, Chen Y, Wang J, Yao K. 2012. The role of MAPK in CD4(+) T cells toll-like receptor 9-mediated signaling following HHV-6 infection. Virology 422:92-98. http://dx.doi.org/10.1016/j.virol.2011.09.026.
62. Bowman CC, Rasley A, Tranguch SL, Marriott I. 2003. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43:281-291. http://dx.doi.org/10.1002/glia.10256.
63. McKimmie CS, Fazakerley JK. 2005. In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J. Neuroimmunol. 169:116-125. http://dx.doi.org/10.1016/j.jneuroim.2005.08.006.
64. El-Hage N, Podhaizer EM, Sturgill J, Hauser KF. 2011. Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. Immunol. Investig. 40:498-522. http://dx.doi.org/10.3109/08820139.2011.561904.
65. Yao K, Crawford JR, Komaroff AL, Ablashi DV, Jacobson S. 2010. Review part 2: human herpesvirus-6 in central nervous system diseases. J. Med. Virol. 82:1669-1678. http://dx.doi.org/10.1002/jmv.21861.
66. Reynaud JM, Horvat B. 2013. Human herpesvirus 6 and neuroinflammation. ISRN Virol. 2013:11. http://dx.doi.org/10.3389/fmicb.2013.00174.
67. Mori Y, Seya T, Huang HL, Akkapaiboon P, Dhepakson P, Yamanishi K. 2002. Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J. Virol. 76:6750-6761. http://dx.doi.org/10.1128/JVI.76.13.6750-6761.2002.
68. Taniguchi T, Shimamoto T, Isegawa Y, Kondo K, Yamanishi K. 2000. Structure of transcripts and proteins encoded by U79-80 of human herpesvirus 6 and its subcellular localization in infected cells. Virology 271: 307-320. http://dx.doi.org/10.1006/viro.2000.0326.
69. Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D. 1998. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl. Acad. Sci. U. S. A. 95:13911-13916. http://dx.doi.org/10.1073/pnas.95.23.13911.
70. Caselli E, Bracci A, Galvan M, Boni M, Rotola A, Bergamini C, Cermelli C, Dal Monte P, Gompels UA, Cassai E, Di Luca D. 2006. Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication. Virology 346:402-414. http://dx.doi.org/10.1016/j.virol.2005.11.018.
71. Chi J, Gu B, Zhang C, Peng G, Zhou F, Chen Y, Zhang G, Guo Y, Guo D, Qin J, Wang J, Li L, Wang F, Liu G, Xie F, Feng D, Zhou H, Huang X, Lu S, Liu Y, Hu W, Yao K. 2012. Human herpesvirus 6 latent infection in patients with glioma. J. Infect. Dis. 206:1394-1398. http://dx.doi.org/10.1093/infdis/jis513.
72. Mrkic B, Pavlovic J, Rülicke T, Volpe P, Buchholz CJ, Hourcade D, Atkinson JP, Aguzzi A, Cattaneo R. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7427.
73. Jaworska J, Gravel A, Flamand L. 2010. Divergent susceptibilities of human herpesvirus 6 variants to type I interferons. Proc. Natl. Acad. Sci. U. S. A. 107:8369-8374. http://dx.doi.org/10.1073/pnas.0909951107.
74. Caselli E, Zatelli MC, Rizzo R, Benedetti S, Martorelli D, Trasforini G, Cassai E, Degli Uberti EC, Di Luca D, Dolcetti R. 2012. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog. 8:e1002951. http://dx.doi.org/10.1371/journal.ppat.1002951.
75. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175:4320-4330.
76. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374. http://dx.doi.org/10.1002/glia.20117.
77. Li K, Feito MJ, Sacks SH, Sheerin NS. 2006. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J. Immunol. 177: 2543-2551.
78. Gerlier D, Trescol-Biémont MC, Varior-Krishnan G, Naniche D, Fugier-Vivier I, Rabourdin-Combe C. 1994. Efficient MHC class IIrestricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway. Cell Biol. Int. 18:315-320. http://dx.doi.org/10.1006/cbir.1994.1080.
79. Rivailler P, Trescol-Biémont MC, Gimenez C, Rabourdin-Combe C, Horvat B. 1998. Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46. Eur. J. Immunol. 28:1301-1314. http://dx.doi.org/10.1002/(SICI)152 1-4141(199804)28:04<1301::AID-IMMU13013.0.CO;2-S.
80. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, Piesche M, Schroers R, Weiss E, Kirschning CJ, Rochford CDP, Brück W, Becher B. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Investig. 116:456- 464. http://dx.doi.org/10.1172/JCI26078.
81. Wang G, Liszewski MK, Chan AC, Atkinson JP. 2000. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J. Immunol. 164:1839-1846. http://www.jimmunol.org/content/16 4/4/1839.
82. Zaffran Y, Destaing O, Roux A, Ory S, Nheu T, Jurdic P, Rabourdin-Combe C, Astier AL. 2001. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167:6780-6785. http://www.jimmunol.org/content/167/12/6780.
83. Ludford-Menting MJ, Thomas SJ, Crimeen B, Harris LJ, Loveland BE, Bills M, Ellis S, Russell SM. 2002. A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J. Biol. Chem. 277: 4477-4484. http://dx.doi.org/10.1074/jbc.M108479200.
84. Greenstone HL, Santoro F, Lusso P, Berger EA. 2002. Human herpesvirus 6 and measles virus employ distinct cd46 domains for receptor function. J. Biol. Chem. 277:39112-39118. http://dx.doi.org/10.1074/jbc.M20 6488200.
85. Mori Y, Akkapaiboon P, Yonemoto S, Koike M, Takemoto M, Sadaoka T, Sasamoto Y, Konishi S, Uchiyama Y, Yamanishi K. 2004. Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J. Virol. 78:4609-4616. http://dx.doi.org/10.1128/JVI.78.9.4609-4616.2004.